KP-102 organo-vanadium small molecule insulin sensitizer: Began Phase I testing

By WIR Staff | Jan 4, 1999 | 8:00 AM GMT

Kinetek Pharmaceutical Inc., Vancouver, B.C.

Read the full 55 word article

How to gain access

Continue reading with a
two-week free trial.